Literature DB >> 21470290

e-SPC - delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers.

Simon Maxwell1, Hans-Georg Eichler, Anna Bucsics, Walter E Haefeli, Lars L Gustafsson.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 21470290      PMCID： PMC3248251          DOI： 10.1111/j.1365-2125.2011.03981.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  14 in total

Review 1.  From best evidence to best practice: effective implementation of change in patients' care.

Authors:  Richard Grol; Jeremy Grimshaw
Journal:  Lancet       Date:  2003-10-11       Impact factor: 79.321

2.  CPOE and clinical decision support in hospitals: getting the benefits: comment on "Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction".

Authors:  David W Bates
Journal:  Arch Intern Med       Date:  2010-09-27

3.  Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial.

Authors:  Brian L Strom; Rita Schinnar; Faten Aberra; Warren Bilker; Sean Hennessy; Charles E Leonard; Eric Pifer
Journal:  Arch Intern Med       Date:  2010-09-27

4.  Tablet splitting: patients and physicians need better support.

Authors:  R Quinzler; J Szecsenyi; W E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2007-12       Impact factor: 2.953

5.  Clinical pharmacology information in summaries of product characteristics and package inserts.

Authors:  B Arguello; F Fernandez-Llimos
Journal:  Clin Pharmacol Ther       Date:  2007-04-04       Impact factor: 6.875

6.  The use of health information technology in seven nations.

Authors:  Ashish K Jha; David Doolan; Daniel Grandt; Tim Scott; David W Bates
Journal:  Int J Med Inform       Date:  2008-07-25       Impact factor: 4.046

7.  Successful strategy to improve the specificity of electronic statin-drug interaction alerts.

Authors:  Hanna Marita Seidling; Caroline Henrike Storch; Thilo Bertsche; Christian Senger; Jens Kaltschmidt; Ingeborg Walter-Sack; Walter Emil Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2009-07-30       Impact factor: 2.953

8.  Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands.

Authors:  Anne J Leendertse; Antoine C G Egberts; Lennart J Stoker; Patricia M L A van den Bemt
Journal:  Arch Intern Med       Date:  2008-09-22

9.  Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?

Authors:  Meret Martin-Facklam; Jens Rengelshausen; Yorki Tayrouz; Nahal Ketabi-Kiyanvash; Heike Lindenmaier; Verena Schneider; Verena Bergk; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2004-12-14       Impact factor: 2.953

10.  Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.

Authors:  Emma C Davies; Christopher F Green; Stephen Taylor; Paula R Williamson; David R Mottram; Munir Pirmohamed
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240
View more
  12 in total

1.  Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment.

Authors:  Teresa M Salgado; Blanca Arguello; Fernando Martinez-Martinez; Shalom I Benrimoj; Fernando Fernandez-Llimos
Journal:  Eur J Clin Pharmacol       Date:  2013-07-25       Impact factor: 2.953

2.  Development of a standardized knowledge base to generate individualized medication plans automatically with drug administration recommendations.

Authors:  Alexander F J Send; Adel Al-Ayyash; Sabrina Schecher; Gottfried Rudofsky; Ulrike Klein; Matthias Schaier; Markus G Pruszydlo; Diana Witticke; Kristina Lohmann; Jens Kaltschmidt; Walter E Haefeli; Hanna M Seidling
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

Review 3.  Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response.

Authors:  Hans-Georg Eichler; Eric Abadie; Alasdair Breckenridge; Bruno Flamion; Lars L Gustafsson; Hubert Leufkens; Malcolm Rowland; Christian K Schneider; Brigitte Bloechl-Daum
Journal:  Nat Rev Drug Discov       Date:  2011-07-01       Impact factor: 84.694

4.  Definition of variables required for comprehensive description of drug dosage and clinical pharmacokinetics.

Authors:  Anna V Medem; Hanna M Seidling; Hans-Georg Eichler; Jens Kaltschmidt; Michael Metzner; Carina M Hubert; David Czock; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2017-02-14       Impact factor: 2.953

5.  The continuing challenge of providing drug information services to diminish the knowledge--practice gap in medical practice.

Authors:  Gunnar Alván; Marine L Andersson; Annika B Asplund; Ylva Böttiger; Carl-Eric Elwin; Lars L Gustafsson; Birgitta Öhman; Elisabeth Törnqvist
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

6.  Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.

Authors:  J Reis-Pardal; A Rodrigues; E Rodrigues; F Fernandez-Llimos
Journal:  Pharmacogenomics J       Date:  2016-05-31       Impact factor: 3.550

7.  Assessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation.

Authors:  Blanca Arguello; Teresa M Salgado; Fernando Fernandez-Llimos
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

8.  Development of a computerised decisions support system for renal risk drugs targeting primary healthcare.

Authors:  Anders Helldén; Fadiea Al-Aieshy; Pia Bastholm-Rahmner; Ulf Bergman; Lars L Gustafsson; Hans Höök; Susanne Sjöviker; Anders Söderström; Ingegerd Odar-Cederlöf
Journal:  BMJ Open       Date:  2015-07-06       Impact factor: 2.692

9.  Development and evaluation of a computerised clinical decision support system for switching drugs at the interface between primary and tertiary care.

Authors:  Markus G Pruszydlo; Stefanie U Walk-Fritz; Torsten Hoppe-Tichy; Jens Kaltschmidt; Walter E Haefeli
Journal:  BMC Med Inform Decis Mak       Date:  2012-11-27       Impact factor: 2.796

10.  Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobials.

Authors:  Rumiko Shimazawa; Yoshinobu Kano; Masayuki Ikeda
Journal:  Pharmacol Res Perspect       Date:  2018-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.